This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ho, S. K. N.
Right arrow Articles by Lai, K. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ho, S. K. N.
Right arrow Articles by Lai, K. N.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, August 1999, p. 2461-2465, Vol. 37, No. 8
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Comparison of the Second-Generation Digene Hybrid Capture Assay with the Branched-DNA Assay for Measurement of Hepatitis B Virus DNA in Serum

Stephen K. N. Ho, Tak Mao Chan,* Ignatius K. P. Cheng, and Kar Neng Lai

Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China

Received 22 December 1998/Returned for modification 4 March 1999/Accepted 27 April 1999

The optimal hepatitis B virus (HBV) DNA quantitative assay for clinical use remains to be determined. We examined the sensitivity, linearity, and variability of a novel second-generation antibody capture solution hybridization assay, the Digene Hybrid Capture II assay (HCII), and compared it with another widely used solution hybridization assay, the branched-DNA (bDNA) assay (Quantiplex; Chiron Corp.). Our results showed similar and satisfactory assay linearity values, as well as interassay and intra-assay variability values, for both HCII and bDNA assays across different ranges of HBV DNA. Ninety-one percent of 102 serum samples from hepatitis B surface antigen-positive patients showed concordant results with the two assays. The HCII assay was more sensitive than the bDNA assay by 1 dilution, with the lowest reading being 0.9 pg/ml (3.8 pg/ml by bDNA assay). The HBV DNA seropositivity rates for the 102 samples were 58, 67, and 97% by bDNA, HCII, and nested PCR, respectively. While the relationship between results obtained with the bDNA assay and those with the HCII assay was nonlinear, with the bDNA assay yielding values 2.83 ± 0.92-fold higher than those of the HCII assay, especially at high HBV DNA levels, a linear relationship was observed between the two sets of data after logarithmic conversion. The formula for interassay conversion of results was derived as follows: HBV DNA by HCII (picograms per milliliter) = 3.19 × [HBV DNA by bDNA (megaequivalents per milliliter)]0.866. The HCII assay was technically less complex and required a shorter assay time (4 h) than the bDNA assay (24 h). We conclude that the HCII assay compares favorably with the bDNA assay and offers the additional advantages of increased sensitivity and shorter assay time. The increased sensitivity should be particularly useful in monitoring the efficacy of antiviral therapies and detecting the emergence of drug-resistant HBV mutants.

* Corresponding author. Mailing address: Department of Medicine, Queen Mary Hospital, Pokfulam Rd., Hong Kong, China. Phone: 852 2855 4041. Fax: 852 2872 5828. E-mail: dtmchan{at}hku.hk.

Journal of Clinical Microbiology, August 1999, p. 2461-2465, Vol. 37, No. 8
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Konnick, E. Q., Erali, M., Ashwood, E. R., Hillyard, D. R. (2005). Evaluation of the COBAS Amplicor HBV Monitor Assay and Comparison with the Ultrasensitive HBV Hybrid Capture 2 Assay for Quantification of Hepatitis B Virus DNA. J. Clin. Microbiol. 43: 596-603 [Abstract] [Full Text]  
  • Yuan, H.-J., Yuen, M.-F., Wong, D. K.-H., Sum, S. S.-M., Lai, C.-L. (2004). Clinical Evaluation of the Digene Hybrid Capture II Test and the COBAS AMPLICOR Monitor Test for Determination of Hepatitis B Virus DNA Levels. J. Clin. Microbiol. 42: 3513-3517 [Abstract] [Full Text]  
  • Dai, C-Y, Yu, M-L, Chen, S-C, Lin, Z-Y, Hsieh, M-Y, Wang, L-Y, Tsai, J-F, Chuang, W-L, Chang, W-Y (2004). Clinical evaluation of the COBAS Amplicor HBV monitor test for measuring serum HBV DNA and comparison with the Quantiplex branched DNA signal amplification assay in Taiwan. J. Clin. Pathol. 57: 141-145 [Abstract] [Full Text]  
  • Ho, S. K.N., Yam, W.-C., Leung, E. T.K., Wong, L.-P., Leung, J. K.H., Lai, K.-N., Chan, T.-M. (2003). Rapid quantification of hepatitis B virus DNA by real-time PCR using fluorescent hybridization probes. J Med Microbiol 52: 397-402 [Abstract] [Full Text]  
  • Kawaguchi, K., Kaneko, S., Honda, M., Kawai, H. F., Shirota, Y., Kobayashi, K. (2003). Detection of Hepatitis B Virus DNA in Sera from Patients with Chronic Hepatitis B Virus Infection by DNA Microarray Method. J. Clin. Microbiol. 41: 1701-1704 [Abstract] [Full Text]  
  • Marin, I. J., Poljak, M., Seme, K., Meglic-Volkar, J., Maticic, M., Lesnicar, G., Brinovec, V. (2001). Comparative Evaluation of Semiautomated COBAS AMPLICOR Hepatitis B Virus (HBV) MONITOR Test and Manual Microwell Plate-Based AMPLICOR HBV MONITOR Test. J. Clin. Microbiol. 39: 758-761 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»